Comparison of the effects of 0.05% topical cyclosporine A versus 0.1% topical cyclosporine A on recurrence and clinical parameters following pterygium surgery
Turkish Journal of Medical Sciences · 23.08.2024 · 54 (4) · 675-681
DOI: 10.55730/1300-0144.5836 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 23.08.2024. Verfasst von Emin Serbülent Güçlü und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Mersin City Training and Research Hospital, Mersin, Turkiye. Hauptthemen laut MEDLINE: Pterygium, Cyclosporine, Recurrence. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: To compare the efficacy of topical 0.05% cyclosporine A (CsA) and 0.1% topical cyclosporine A (CsA) over a 6-month period following pterygium surgery, specifically evaluating their effects on postoperative recurrence and clinical parameters.Material and methods: This clinical study enrolled 245 patients with pterygium who underwent surgery using the conjunctival autograft technique with mitomycin C (MMC) were enrolled. Participants were divided into three groups: Group 1 (0.05% CsA) (n = 80), Group 2 (0.1% CsA) (n = 80), and a control group (n = 85). They were examined at postoperative first day, first week, first month and sixth month. The examination included best corrected visual acuity (BCVA), intraocular pressure (IOP), presence of inflammation, and ptergium recurrence, all of which were compared across the groups.
Results
The mean age of the patients was 63.22 ± 9.39 years, with 53.3% male and 46.7% female. The three groups were similar in terms of demographic characteristics and pterygium size. Inflammation in surgical area significantly regressed in all groups at 6 months postoperatively (p < 0.05). Inflammation in the first and sixth months was not different between the groups (p = 0.118, p = 0.580, and p = 0.435, respectively). The recurrence rate was not different between groups (p = 0.890). There was no statistically significant difference between groups regarding IOP (p = 0.818). A significant increase in BCVA after surgery was observed in three groups compared to preoperative levels (p < 0.05).
Conclusion
This study showed that there was no difference between the efficacy of 6 month topical 0.05% CsA and 0.1% CsA application after pterygium surgery with the conjunctival autograft technique with MMC on postoperative outcomes. Including postoperative recurrence, IOP changes, BCVA changes and surgical area inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Mersin City Training and Research Hospital, Mersin, Turkiye.
- Department of Ophthalmology, Faculty of Medicine, Niğde Ömer Halisdemir University, Niğde, Turkiye.
ORCID-Profile: Emin Serbülent Güçlü, Tamer Metin, Ömer Özer, Fatma Merve Bektaş
Zitieren
APA
Güçlü, E. S., Metin, T., Özer, Ö., & Bektaş, F. M. (2024). Comparison of the effects of 0.05% topical cyclosporine A versus 0.1% topical cyclosporine A on recurrence and clinical parameters following pterygium surgery. Turkish Journal of Medical Sciences, 54(4), 675-681. https://doi.org/10.55730/1300-0144.5836
Vancouver
Güçlü ES, Metin T, Özer Ö, Bektaş FM. Comparison of the effects of 0.05% topical cyclosporine A versus 0.1% topical cyclosporine A on recurrence and clinical parameters following pterygium surgery. Turkish Journal of Medical Sciences. 2024;54(4):675-681. doi:10.55730/1300-0144.5836
BibTeX
@article{Gl2024,
author = {Güçlü, Emin Serbülent and Metin, Tamer and Özer, Ömer and Bektaş, Fatma Merve},
title = {Comparison of the effects of 0.05% topical cyclosporine A versus 0.1% topical cyclosporine A on recurrence and clinical parameters following pterygium surgery},
journal = {Turkish Journal of Medical Sciences},
year = {2024},
volume = {54},
number = {4},
pages = {675--681},
doi = {10.55730/1300-0144.5836}
}
EUVIMED